Related Experiment Video
Updated: Feb 16, 2026

08:28
Experimental Metastasis Assay
Published on: August 24, 2010
21.0K
A core program of gene expression characterizes cancer metastases
Franz Hartung1, Yunguan Wang2, Bruce Aronow2
1University of Cincinnati Academic Health Center, Cincinnati, OH, USA.
Oncotarget
|December 20, 2017
Summary
Cancer metastasis exhibits a common gene expression program affecting metabolism and tissue interactions. Organ-specific metastasis involves unique genetic adjustments to the micro-environment, potentially guiding targeted cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Metastasis gene expression enables cancer dissemination.
- The genetic basis for organ-specific metastasis remains unclear.
Purpose of the Study:
- Investigate common gene expression signatures in metastases across different sites.
- Determine if these signatures are conserved across cancer types and in a murine model.
- Explore potential therapeutic strategies based on metastatic genetic profiles.
Main Methods:
- Analyzed gene expression profiles from 653 GEO datasets.
- Corroborated findings using a murine metastasis model.
- Compared gene expression in primary tumors, metastases, and host tissues.
Main Results:
- Identified a core gene expression program in metastases affecting metabolism, vascularization, extracellular matrix, and ion homeostasis.
- This program distinguishes metastases from primary tumors and host tissues.
- Site-selectivity is achieved through specific gene expression adjustments to the target micro-environment.
- Similar gene expression programs were observed in B16-F10 cell metastases across various organs.
Conclusions:
- Metastases share common genetic features, but organ preference is modulated by site-specific factors.
- Investigate whether these genetic signatures determine organ preference or result from it.
- Therapeutic strategies targeting the genetic makeup of metastases may improve efficacy over targeting primary tumor origin.
Related Concept Videos
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cancers Originate from Somatic Mutations in a Single Cell
15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K
Cancer-Critical Genes I: Proto-oncogenes
11.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Cancer
54.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.6K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K

